Homocysteine and vascular disease.
Robinson
K
K
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D015415:Biomarkers / Q000097:blood; D003327:Coronary Disease / Q000097:blood / Q000188:drug therapy; D004305:Dose-Response Relationship, Drug; D005492:Folic Acid / Q000097:blood / Q000627:therapeutic use*; D006397:Hematinics / Q000627:therapeutic use*; D006710:Homocysteine / Q000097:blood* / Q000187:drug effects*; D006801:Humans; D011725:Pyridines / Q000627:therapeutic use; D013841:Thiazepines / Q000627:therapeutic use; D014652:Vascular Diseases / Q000097:blood* / Q000188:drug therapy*
D000806:Angiotensin-Converting Enzyme Inhibitors; D015415:Biomarkers; D006397:Hematinics; D011725:Pyridines; D013841:Thiazepines; D006710:Homocysteine; C106266:omapatrilat; D005492:Folic Acid